- Catalogs
- Innobiochips SAS
- CoViDiag+
- Products
- Catalogs
- News & Trends
- Exhibitions
CoViDiag+
CoViDiag+
CoViDiag is a high-resolution serological diagnostic device designed for COVID-19 testing and immune status characterization. Utilizing advanced multiplex SirYus technology, it can detect up to 8 antibodies against SARS-CoV-2 and 4 variants, providing precise and reliable results with comprehensive immune profiling. The device is automatable on mainstream platforms, allowing for high-throughput testing of hundreds of samples daily.
- Unprecedented Performance: The device offers a complete immune profile of patients, enhancing the understanding of biological diversity and improving performance.
- Vaccination vs. Natural Immunity Distinction: It can differentiate between antibodies from vaccination and natural infection, tracking new virus contacts regardless of vaccination status.
- Variant Cross Immunity Monitoring: By measuring antibody reactivity to different variant antigens, it provides insights into cross-reactivity and helps anticipate the need for vaccine boosters.
- Cross Immunity Evaluation: CoViDiag+ offers a comprehensive view of cross immunity by comparing sample reactivity on S1-RBD from SARS-CoV-2 and its variants.
- Antibody Pattern Representation: It correlates IgG titers with neutralizing antibody titers, providing a more representative pattern of immune protection.
SirYus technology revolutionizes in vitro diagnostics by offering a new approach to designing, manufacturing, and reading multiplex immunoassays, paving the way for innovative diagnostic solutions in human health.
Innobiochips is located at Bioincubateur - Parc Eurasanté Lille Métropole, 70 Rue du Dr Yersin, 59120 Loos, France. For inquiries, contact them at [email protected] or +33 (0)3 28 55 51 29.
Catalog excerpts
HD DIAGNOSTIC DEVICE FOR COVID-19 SEROLOGICAL TESTING AND IMMUNE STATUS CHARACTERIZATION
Open the catalog to page 1
ABOUT COVIDIAG CoViDiag is an High-Resolution COVID-19 serological diagnostic device. Developed with the cutting-edge multiplex SirYus technology, it simultaneously detects and identifies up to 8 antibodies produced against the SARS-CoV-2 virus and 4 variants, offering very precise and reliable results, with exhaustive immune profiling. Perfectly automatable on several mainstream devices, CoViDiag is a very competitive technology, that enables to test and characterize several hundreds samples a day. THE KEY POINTS UNPRECEDENTED PERFORMANCES : The combination of Ag enables to get the whole immune...
Open the catalog to page 2
PERFORMANCESAN ANTIBODY PATTERN MORE REPRESENTATIVE OF IMMUNE PROTECTION Correlation of the different IgG titers based on the MSI considered individually, or alltogether (average) with neutralizing antibody titers based on the serum dilution factor to neutralize 90 % of infected cells. When comparing samples reactivity on 5 S1-RBD from SARS-CoV2 and variants, COVIDIAG+ provides the whole spectrum of cross immunity
Open the catalog to page 3
ABOUT INNOBIOCHIPS We develop the SirYus technology, a disruptive way to design, manufacture and read multiplex immunoassays, paving the way for innovative diagnostics solutions for human health. Fast, SirYus level INFECTIOUS DISEASES CONTACT US [email protected] +33 (0)3 28 55 51 29 Bioincubateur - Parc Eurasanté Lille Métropole 70 Rue du Dr Yersin - 59120 Loos - France
Open the catalog to page 4
- Detection kit
- Blood detection kit
- Serum detection kit
- Immunoassay detection kit
- Plasma detection kit
- Infectious disease detection kit
- Respiratory disease assay kit
- ELISA detection kit
- COVID-19 assay kit
- IgG assay kit
- Laboratory assay kit
- Antibody detection kit
- Coronavirus assay kit
- Hematology test kit
- Inflammatory processes test kit
- Diagnostic test kit
- Serology test kit
- Clinical diagnostic immunohematology analyzer
- Automatic immunohematology analyzer
- Immunohematology analyzer